ANA (ENA) specific assays can be qualitative (LIA with the possibility of semi-quantitative interpretation by scanning the lines), semi-quantitative or quantitative, although quantification is justified only for anti-RNP due to the clear association with specific clinical entities (MCTD). This evidence concerns the gene RNPC3 and mixed connective tissue disease.